PetVivo Holdings, Inc. (PETV)

Market Cap	23.23M
Revenue (ttm)	1.31M
Net Income (ttm)	-8.69M
Shares Out	27.90M
EPS (ttm)	-0.40
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	200
Average Volume	11,503
Open	0.8500
Previous Close	0.8000
Day's Range	0.8500 - 0.8500
52-Week Range	0.3960 - 0.9800
Beta	0.67
RSI	54.20
Earnings Date	Aug 8, 2025

About PetVivo Holdings

PetVivo Holdings, Inc., a biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals in the United States. The company’s lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. It also provides therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. is headquartered in Edina, Minnesota.

• Industry: Medical Devices
• Sector: Healthcare
• CEO: John Lai
• Employees: 24
• Stock Exchange: OTCMKTS
• Ticker Symbol: PETV

Financial Performance

In 2024, PetVivo Holdings's revenue was $1.13 million, an increase of 16.91% compared to the previous year's $968,706. Losses were -$8.40 million, -23.33% less than in 2023.